UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report  (Date of earliest event reported): October 15, 2010

NATURE’S SUNSHINE PRODUCTS, INC.

(Exact Name of Registrant as Specified in its Charter)

Registrant’s telephone number, including area code: (801) 342-4300

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Cautionary Statement Regarding Forward-Looking Statements

In addition to historical information, this report contains forward-looking statements.  Nature’s Sunshine may, from time to time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Such statements encompass Nature’s Sunshine’s beliefs, expectations, hopes, or intentions regarding future events.  Words such as “expects,” “intends,” “believes,” “anticipates,” “should,” “likely,” and similar expressions identify forward-looking statements.  All forward-looking statements included in this report are made as of the date hereof and are based on information available to the Company as of such date. Nature’s Sunshine assumes no obligation to update any forward-looking statement. Actual results will vary, and may vary materially, from those anticipated, estimated, projected or expected for a number of reasons, including, among others: further reviews of the Company’s financial statements by the Company and its Audit Committee; modification of the Company’s accounting practices; the outcome of the various inquiries, requests for documents and proceedings by government agencies; foreign business risks; industry cyclicality; fluctuations in customer demand and order pattern; changes in pricing and general economic conditions; as well as other risks detailed in the Company’s previous filings with the SEC.

Item 5.02               Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On October 14, 2010, Nature’s Sunshine Products, Inc. (the “Company”) issued a press release announcing that Greg Halliday had decided to step down from his position as Executive Vice President — U.S. Sales effective immediately, as well as the appointment of Efrain Villalobos, Divisional Vice President — U.S. Sales, as Executive Vice President — U.S. Sales. In addition, Craig Dalley, Divisional Vice President, was promoted to Vice President — U.S. Sales.

Efrain Villalobos has served since March 2009 as Divisional Vice President — Spanish U.S. Sales with primary responsibility over the Company’s domestic Spanish speaking sales and sales in the Dominican Republic.  Craig Dalley most recently served as Divisional Vice President — U.S. Sales.

On October 15, 2010, the Company issued a press release announcing the resignation of Pauline Hughes Francis from its Board of Directors. Ms. Hughes Francis provided notice of her resignation to the Board of Directors on October 11, 2010, effective immediately. Ms. Hughes Francis was a founder in 1972 of Hughes Development Corporation, a predecessor of the Company, and was originally appointed to the Board in 1988.  She has served on a number of Board committees and was most recently elected as a Class III Director during the 2009 Annual Meeting.  Prior to her resignation, Ms. Hughes Francis served as Chair of the Nominations Committee.

Item 9.01               Financial Statements and Exhibits

(d)           The following documents are filed as exhibits to this report:

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

3